Position in PBYI
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$3,413,710
+$2,656,204 QoQ
Shares Held
534,227
+319.6% QoQ
Ownership
1.05%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in PBYI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS Group AG holds $7,583,514,316 across 563 Biotechnology names. PBYI ranks #163 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
22,619,472 | $626,559,372 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
5,177,796 | $545,739,697 | |
| 3 | ABVX |
Abivax S.A.
|
4,547,406 | $506,353,656 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
4,386,791 | $426,615,424 | |
| 5 | INSM |
INSMED Inc
|
1,737,481 | $284,112,890 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
630,618 | $281,596,158 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
299,979 | $231,775,770 | |
| 8 | MRNA |
Moderna, Inc.
|
4,407,907 | $223,921,674 |
All Filings in PBYI
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,413,710 | 534,227 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $757,506 | 127,312 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $1,997,043 | 376,091 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $940,162 | 274,100 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $827,813 | 279,667 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $474,490 | 155,571 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $69,088 | 27,094 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $66,265 | 20,327 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $56,406 | 10,643 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $48,161 | 11,123 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $8,957 | 3,406 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $14,331 | 4,060 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $33,757 | 10,925 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $14,551 | 3,440 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $8,117 | 3,425 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $12,935 | 4,539 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $74,836 | 25,985 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $53,083 | 17,462 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $45,733 | 6,524 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $94,415 | 10,285 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $557,305 | 57,336 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $95,294 | 9,288 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $1,603,886 | 158,958 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $1,663,470 | 159,489 | Shares | Defined | 2020-07-31 | |
| 2020-03-31 | $1,388,354 | 164,497 | Shares | Defined | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||